Pluri Inc. Operating Lease, Payments
Pluri Inc. (PLUR) reported Operating Lease, Payments of $106.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-09-10
- Pluri Inc. operating lease, payments for the quarter ending 2020-06-30 was $0.00.
- Pluri Inc. operating lease, payments for the quarter ending 2020-03-31 was $83.00K.
- Pluri Inc. operating lease, payments for fiscal 2026 was $106.00K, a 523.53% increase from fiscal 2025.
- Pluri Inc. operating lease, payments for fiscal 2025 was $17.00K, a 78.21% decline from fiscal 2024.
- Pluri Inc. operating lease, payments for fiscal 2024 was $78.00K.
- Pluri Inc. operating lease, payments for fiscal 2022 was $8.25M, a 5257.14% increase from fiscal 2021.
USD
| Period end | Operating Lease, Payments | Operating Lease, Payments as first filed | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $106.00K 10-K · filed 2026-09-10 | ||||||
| 2025-06-30 | $17.00K 10-K · filed 2026-09-10 | $80.00K 10-K · filed 2025-09-17 | |||||
| 2024-10-31 | $15.00K 10-K · filed 2025-09-17 | $14.00K 10-Q · filed 2024-11-12 | |||||
| 2024-06-30 | $78.00K 10-K · filed 2024-09-18 | ||||||
| 2022-06-30 | $8.25M 10-K · filed 2022-09-21 | ||||||
| 2021-06-30 | $154.00K 10-K · filed 2022-09-21 | ||||||
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-13 | $83.00K derived: sum of 2 quarters · filed 2021-09-13 | $83.00K 10-K · filed 2021-09-13 | ||||
| 2020-03-31 | $83.00K 10-Q · filed 2020-05-11 | $83.00K 10-Q · filed 2020-05-11 |
ILS
| Period end | Operating Lease, Payments | Operating Lease, Payments as first filed | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|
| 2026-06-30 | 335.00M ILS 10-K · filed 2026-09-10 | |||
| 2025-06-30 | 55.00M ILS 10-K · filed 2026-09-10 | 292.00K ILS 10-K · filed 2025-09-17 | ||
| 2024-10-31 | 55.00K ILS 10-K · filed 2025-09-17 | 50.19M ILS 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | 292.00K ILS 10-K · filed 2024-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |